Browse Category

LSE:ICG News 19 January 2026

ICG plc share price slips nearly 2% as tariff jitters rattle Europe; Jan 21 update in focus

ICG plc share price slips nearly 2% as tariff jitters rattle Europe; Jan 21 update in focus

London, January 19, 2026, 10:21 GMT — Regular session underway. ICG plc shares dropped almost 2% Monday morning, dragged down by a wider selloff in European stocks as investors pared risk following new U.S. tariff warnings. (ICG) The decline is significant since ICG stands at the intersection of market sentiment: policy disruptions often stall deal flow, exits, and fundraising, while…

Stock Market Today

  • 10x Genomics (TXG) Stock Valuation Examined After Sharp Price Gains
    January 23, 2026, 12:15 PM EST. 10x Genomics (TXG) has seen a recent share price surge with a 40.55% increase over one month and a 68.41% rise in 90 days, driven by investor interest in genomics tools. Despite this momentum, the stock trades at $23.19, above the average analyst price target of $18.23 and a narrative-based fair value of $17.36, suggesting possible overvaluation. The company's acquisition of Scale Biosciences enhances its single-cell analysis capabilities, potentially boosting future revenue and margins. Risks remain, including reduced research funding and pricing pressures that may affect growth expectations. Investors are urged to weigh these factors as 10x Genomics' long-term total shareholder returns have been weaker. The stock's elevated price demands careful consideration of the underlying growth story and market assumptions.
Go toTop